Anna Hultberg

1.8k total citations
30 papers, 1.1k citations indexed

About

Anna Hultberg is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Anna Hultberg has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Immunology. Recurrent topics in Anna Hultberg's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (9 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Anna Hultberg is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (9 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Anna Hultberg collaborates with scholars based in Belgium, Netherlands and Sweden. Anna Hultberg's co-authors include Lennart Hammarström, Harold Marcotte, Theo Verrips, Peter Vanlandschoot, Bert Schepens, Xavier Saelens, Lorena Itatí Ibañez, Peter H. Pouwels, Qiang Pan‐Hammarström and Robin A. Weiss and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Anna Hultberg

29 papers receiving 1.1k citations

Peers

Anna Hultberg

RNMI

IMMUN

EPIDE

W Stok Czechia

M P Dierich Austria

Eiríkur Saeland Netherlands

Farzin Roohvand Iran

A Hohmann Australia

Miriam J.J.G. Poppelier Netherlands

Hans B. Lomholt Denmark

Ulrich von Pawel‐Rammingen Sweden

Måns Ullberg Sweden

M.A. Julie Westerink United States

W Stok Czechia

Anna Hultberg

556 ×1.2

398 ×0.9

RNMI

397 ×1.6

IMMUN

197 ×0.8

55 ×0.3

EPIDE

Citations per year, relative to Anna Hultberg Anna Hultberg (= 1×) peers W Stok

Countries citing papers authored by Anna Hultberg

Since Specialization

Citations

This map shows the geographic impact of Anna Hultberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Hultberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Hultberg more than expected).

Fields of papers citing papers by Anna Hultberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Hultberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Hultberg. The network helps show where Anna Hultberg may publish in the future.

Co-authorship network of co-authors of Anna Hultberg

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Hultberg. A scholar is included among the top collaborators of Anna Hultberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Hultberg. Anna Hultberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Broome, Catherine M., Vickie McDonald, Yoshitaka Miyakawa, et al.. (2023). Time to Achieve Platelet Count Response after Intravenous Efgartigimod in Adults with Primary Immune Thrombocytopenia: A Phase 3, Multicenter, Double-Blinded, Placebo-Controlled, Randomized Clinical Trial (ADVANCE IV). Blood. 142(Supplement 1). 689–689. 1 indexed citations

Pabst, Thomas, Norbert Vey, Lionel Adès, et al.. (2023). Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy. Haematologica. 108(7). 1793–1802. 25 indexed citations

Aftimos, Philippe, Christian Rolfo, Sylvie Rottey, et al.. (2017). Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies. Clinical Cancer Research. 23(21). 6411–6420. 47 indexed citations

Godar, Marie, Virginia Morello, Anna Hultberg, et al.. (2016). Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy. Scientific Reports. 6(1). 31621–31621. 13 indexed citations

Blanchetot, Christophe, Natalie De Jonge, Aline Desmyter, et al.. (2016). Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies. Journal of Biological Chemistry. 291(26). 13846–13854. 28 indexed citations

Klarenbeek, A., Christophe Blanchetot, Wieger Hemrika, et al.. (2016). Combining somatic mutations present in differentin vivoaffinity-matured antibodies isolated from immunizedLama glamayields ultra-potent antibody therapeutics. Protein Engineering Design and Selection. 29(4). 123–133. 9 indexed citations

Woning, Bas van der, Gitte De Boeck, Christophe Blanchetot, et al.. (2016). DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops. mAbs. 8(6). 1126–1135. 26 indexed citations

Klarenbeek, A., Aline Desmyter, Christophe Blanchetot, et al.. (2015). Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform. mAbs. 7(4). 693–706. 74 indexed citations

Hanssens, Valérie, Natalie De Jonge, Anna Hultberg, et al.. (2015). The clinical potential of ARGX-111, an afucosylated anti-MET antibody, in hematological malignancies and suppression of metastasis. Annals of Oncology. 26. ii31–ii31. 3 indexed citations

10.

Hultberg, Anna, Heidi Rommelaere, Angela Wittelsberger, et al.. (2014). Protective Effect of Different Anti-Rabies Virus VHH Constructs against Rabies Disease in Mice. PLoS ONE. 9(10). e109367–e109367. 34 indexed citations

11.

Basilico, Cristina, Anna Hultberg, Christophe Blanchetot, et al.. (2014). Four individually druggable MET hotspots mediate HGF-driven tumor progression. Journal of Clinical Investigation. 124(7). 3172–3186. 41 indexed citations

12.

Schepens, Bert, Lorena Itatí Ibañez, Anna Hultberg, et al.. (2011). Nanobodies® Specific for Respiratory Syncytial Virus Fusion Protein Protect Against Infection by Inhibition of Fusion. The Journal of Infectious Diseases. 204(11). 1692–1701. 43 indexed citations

13.

Ibañez, Lorena Itatí, Marina De Filette, Anna Hultberg, et al.. (2011). Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection. The Journal of Infectious Diseases. 203(8). 1063–1072. 85 indexed citations

14.

Hultberg, Anna, Nigel Temperton, Valérie Rosseels, et al.. (2011). Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules. PLoS ONE. 6(4). e17665–e17665. 144 indexed citations

15.

Ångström, Jonas, Adnan Halim, Anna Hultberg, et al.. (2008). Novel Leb-like Helicobacter pylori-binding glycosphingolipid created by the expression of human -1,3/4-fucosyltransferase in FVB/N mouse stomach. Glycobiology. 19(2). 182–191. 10 indexed citations

16.

Hultberg, Anna, Denise M. Tremblay, Hans de Haard, et al.. (2007). Lactobacillli expressing llama VHH fragments neutralise Lactococcusphages. BMC Biotechnology. 7(1). 58–58. 23 indexed citations

17.

Pant, Neha, Anna Hultberg, Yaofeng Zhao, et al.. (2006). Lactobacilli Expressing Variable Domain of Llama Heavy‐Chain Antibody Fragments (Lactobodies) Confer Protection against Rotavirus‐Induced Diarrhea. The Journal of Infectious Diseases. 194(11). 1580–1588. 111 indexed citations

18.

Hultberg, Anna, Harold Marcotte, Pim Hermans, et al.. (2006). Therapeutic effect of llama derived VHH fragments against Streptococcus mutans on the development of dental caries. Applied Microbiology and Biotechnology. 72(4). 732–737. 26 indexed citations

19.

Marcotte, Harold, Anna Hultberg, Yaofeng Zhao, et al.. (2005). Expression of single-chain antibody against RgpA protease of Porphyromonas gingivalis in Lactobacillus. Journal of Applied Microbiology. 100(2). 256–263. 36 indexed citations

20.

Hultberg, Anna, et al.. (2005). Passive Immunization by Lactobacilli Expressing Single-Chain Antibodies Against <I>Streptococcus mutans</I>. Molecular Biotechnology. 31(3). 221–232. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact